Related Experiment Video
Updated: Aug 11, 2026
Murine Prostate Micro-dissection and Surgical Castration
Published on: May 11, 2016
[Mechanism of loss of androgen dependency in androgen-dependent tumor]
N Sato1, H Suzuki, J Shimazaki
1Department of Urology, School of Medicine, Chiba University, Japan.
Abstract:
Human prostatic cancer is androgen sensitive tumor but gradually loses its androgen sensitivity during progression. Amount of androgen receptors usually correlates with androgen sensitivity. Mutation of androgen receptor gene is attributable to be one reason for androgen insensitivity. Alternatively, it is shown that a murine androgen insensitive tumor derived from androgen dependent one possesses functional androgen receptors without structural abnormality. A series of gene mutation, especially with relation to genes encoding growth factors, may be an important change for progression from androgen sensitive tumor to insensitive one.
Insights
Prostate cancer initially responds to androgen deprivation but can become resistant. Gene mutations, particularly in growth factor pathways, may drive this progression to androgen insensitivity, even with functional androgen receptors.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Context:
- Human prostatic cancer is initially androgen-sensitive.
- Tumor progression often leads to androgen insensitivity.
- Androgen receptor (AR) levels typically correlate with sensitivity.
Purpose:
- To investigate the molecular mechanisms underlying the transition of prostate cancer from androgen sensitivity to insensitivity.
- To explore the role of gene mutations, including those in growth factor genes, in this progression.
Summary:
- Androgen insensitivity in advanced prostate cancer can occur despite the presence of functional androgen receptors without structural abnormalities.
- Gene mutations, particularly those affecting growth factor signaling pathways, are implicated as a key factor in the development of androgen insensitivity.
- While AR gene mutations can cause insensitivity, alternative mechanisms involving other genetic alterations are also significant.
Impact:
- Understanding these mechanisms is crucial for developing new therapeutic strategies targeting advanced or resistant prostate cancer.
- Identifies potential genetic markers for predicting treatment response and disease progression.
- Highlights the importance of considering non-AR mutations in therapeutic resistance.
More Related Videos
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
08:36Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses
Published on: October 24, 2019
Related Concept Videos
02:23Abnormal Proliferation
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
02:56Treatment Resistant Cancers
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...